Explore

Tempus AI Seeks Computational Biologist for Pharma R in Boston

Tempus AI Seeks Computational Biologist for Pharma R in Boston

Tempus AI Seeks Computational Biologist for Pharma R in Boston

AI Genome Analysis Raises Concerns Over Standards and Clinical Interpretation

AI Genome Analysis Raises Concerns Over Standards and Clinical Interpretation

Artificial intelligence (AI) is rapidly advancing the accessibility and speed of genome analysis, with systems like Claude now capable of interpreting entire genomes in minutes for a minimal cost. This marks a significant shift from the past, where such analyses required extensive human expertise and time. For example, a task that once took a team of 30 people nearly a year to complete can now be attempted by AI in about 30 minutes for approximately $5. While AI can re-identify important genetic findings, including disease risks and medication responses, its interpretations are influenced by factors such as the reference genome used and the sequencing technology. Many existing genomes were produced using 'short-read sequencing,' which can be unreliable in complex or repetitive DNA regions where disease-causing variants might occur. Furthermore, current reference genomes often do not adequately represent the full diversity of human genomes, potentially making variant detection difficult in under-represented...

Tiny Health Secures $33 Million to Advance Microbiome Research and AI-Powered Health Coaching

Tiny Health Secures $33 Million to Advance Microbiome Research and AI-Powered Health Coaching

Tiny Health, a company specializing in microbiome testing, has successfully raised $33 million in an oversubscribed Series B funding round, bringing its total capital raised to $46 million. The funding, led by B Capital, will be used to advance research, expand provider education, scale its B2B platform, and enhance its patient-facing AI agent, TinyAI. Tiny Health offers at-home gut testing kits that analyze stool samples to provide personalized reports with recommendations on supplements, diet, and lifestyle. These reports are powered by TinyAI, a large language model trained on nearly 200,000 proprietary microbiome profiles. The company emphasizes that its tests are for wellness, not diagnosis, and has published research demonstrating the effectiveness of targeted microbiome interventions, including health coaching, in reducing the odds of eczema in infants by 83%.

HHS Launches SURPASS Program to Revolutionize Clinical Trial Design with AI

HHS Launches SURPASS Program to Revolutionize Clinical Trial Design with AI

The U.S. Department of Health and Human Services (HHS) has initiated the SURPASS program, an AI-driven effort aimed at transforming clinical trial design and execution. This five-year program, operated by the Advanced Research Projects Agency for Health (ARPA-H), seeks to move beyond traditional fixed-phase trials by integrating predictive computational models, continuous analysis, and automated operations. SURPASS, which stands for Simulation-augmented, Real-time Platform Adaptive Seamless Trials, is designed to identify hidden protocol risks, such as overly restrictive eligibility criteria and patient dropout patterns, through AI-driven simulations. The initiative combines adaptive platform trial design, AI-enabled site activation, a nationwide data infrastructure, and patient data contribution tools. This comprehensive approach is intended to reduce trial timelines, costs, and patient burden, ultimately speeding up the development of new drugs and therapies. The program is part of a larger federal initi...

Creatinine Blood Test: Understanding Muscle Mass and Kidney Function Beyond a Single Value

Creatinine Blood Test: Understanding Muscle Mass and Kidney Function Beyond a Single Value

A creatinine blood test, a common screen for kidney function, measures a waste product released by muscles. Creatinine is formed when creatine, stored in muscles to power contractions, breaks down. Approximately 2% of the body's creatine converts to creatinine daily, making the test reflect muscle mass almost as much as kidney function. Healthy kidneys filter creatinine out of the bloodstream at a steady rate. An elevated creatinine level can indicate either reduced kidney clearance or increased production by the body. Factors like substantial muscle mass, recent intense exercise, creatine supplementation, or a large cooked-meat meal can raise creatinine levels without necessarily indicating kidney problems. Typical adult reference ranges are roughly 0.74–1.35 mg/dL for men and 0.59–1.04 mg/dL for women, but these ranges are influenced by individual muscle mass, age, and sex. The test is often part of a metabolic panel and is interpreted alongside the estimated glomerular filtration rate (eGFR), which comb...

Wearable Health Technology Shifts Towards Medical-Grade Accuracy and Robust Sensor Fusion

Wearable Health Technology Shifts Towards Medical-Grade Accuracy and Robust Sensor Fusion

The global market for wearable health technology is undergoing a significant transformation, moving beyond basic consumer gadgets to sophisticated, multi-sensor biometric diagnostic tools. Procurement managers, healthcare providers, and retail buyers are now prioritizing medical-grade accuracy, robust sensor fusion, strict data compliance, and resilient supply chains. Modern wearable devices are utilizing Sensor Fusion Algorithms to integrate data from various sensors, such as 6-axis accelerometers, optical PPG arrays, galvanic skin response (GSR) electrodes, and ambient temperature sensors. This allows for more accurate distinctions between physical exertion and psychological stress. Companies are focusing on hardware platforms with integrated Neural Network Processing Units (NPUs) for on-device edge computing, enabling rapid analysis of health events without constant smartphone connectivity. There is also a growing demand for non-invasive continuous glucose and metabolic indicator monitoring, with multi-...

UVM Receives $38 Million Contract to Develop AI-Powered 'Digital Twins' for ICU Care

UVM Receives $38 Million Contract to Develop AI-Powered 'Digital Twins' for ICU Care

The University of Vermont (UVM) Larner College of Medicine, led by trauma surgeon and researcher Gary An, M.D., has secured a research and development contract worth up to $38 million. This funding, the largest in UVM's history, is from the Advanced Research Projects Agency for Health (ARPA-H), a federal agency within the U.S. Department of Health and Human Services. The initiative aims to develop artificial intelligence-powered 'digital twins' to personalize treatment for critically ill patients. These digital twins are mathematical models that use real-time patient data, including frequent blood samples and physiological monitoring, to predict disease progression and evaluate potential treatment strategies. The project, known as ReSCUED (Reprogramming Severe Critical Illness Using Extensible Digital Twins), focuses on addressing disordered immune responses in conditions like severe trauma, burns, and sepsis. Researchers believe this technology could reduce intensive care unit (ICU) stays by at least 25 p...

Armani Manov of University of Pittsburgh Advances Neurosurgical Research and Patient Care

Armani Manov of University of Pittsburgh Advances Neurosurgical Research and Patient Care

Armani Manov, a communications coordinator and alumnus of the University of Pittsburgh, is actively engaged in neurosurgical research. His work focuses on surgical innovation and providing care for patients with complex medical conditions. Manov's research integrates clinical experience with outcome analysis to enhance treatments and strengthen evidence-based spine surgery practices. A significant aspect of his role involves translating and disseminating neurosurgical research, with a particular emphasis on how patients are counseled during critical decision-making points regarding their care. He advocates for active patient participation, believing that patient-centered care relies on clear, evidence-based information about conditions, treatment options, and their implications for recovery and quality of life. This approach aims to make information accessible, supporting genuine shared decision-making and ultimately leading to better engagement and outcomes. Furthermore, Manov is exploring the use of data...

Southern Illinois University Researchers Utilize AI to Accelerate Bacteria Detection

Southern Illinois University Researchers Utilize AI to Accelerate Bacteria Detection

Researchers at Southern Illinois University Carbondale are employing artificial intelligence (AI) to significantly speed up the analysis of bacterial changes following antibiotic introduction. This new method reduces the time required for detection from several days to just a few hours. The traditional process of analyzing how single-cell bacteria react to antibiotics typically involves manual observation, which is time-consuming and prone to errors. The AI model, developed by researchers Li and Tragoudas, analyzes real-time imaging of microscopic fluid samples containing bacteria, such as E. coli, exposed to varying concentrations of antibiotics. This innovation addresses a critical need in healthcare, as the misuse or overuse of antibiotics, often due to slow diagnostic results, contributes to antimicrobial resistance (AMR). The Centers for Disease Control and Prevention (CDC) reports over 2.8 million AMR infections annually in the U.S., leading to more than 35,000 deaths and $4.6 billion in healthcare c...

Tempus AI Receives FDA Clearance for AI Tool to Detect Mitral Regurgitation from ECGs

Tempus AI Receives FDA Clearance for AI Tool to Detect Mitral Regurgitation from ECGs

Tempus AI has secured U.S. FDA 510(k) clearance for its new artificial intelligence tool, Tempus ECG-MR. This software is designed to identify indicators of previously undiagnosed moderate or severe mitral regurgitation using standard 12-lead electrocardiograms (ECGs). The tool provides a binary result, signaling whether an ECG contains patterns associated with the condition. It is specifically intended for patients aged 65 and older who have cardiovascular risk factors or symptoms suggestive of heart disease. The AI analyzes resting, non-ambulatory ECGs collected in healthcare facilities, looking for specific patterns linked to mitral regurgitation, a condition where the heart's mitral valve fails to close properly, leading to backward blood flow. This clearance marks Tempus AI's fourth FDA-cleared ECG-AI product, expanding its cardiovascular diagnostic portfolio.

Tempus AI Seeks Senior Privacy Counsel to Bolster HIPAA Compliance Amidst AI and Healthcare Operations

Tempus AI Seeks Senior Privacy Counsel to Bolster HIPAA Compliance Amidst AI and Healthcare Operations

Tempus AI Seeks Senior Privacy Counsel to Bolster HIPAA Compliance Amidst AI and Healthcare Operations

AI Models Show Improved Diagnostic Accuracy in Dermatologic Imaging with Structured Reports and Retrieval Augmentation

AI Models Show Improved Diagnostic Accuracy in Dermatologic Imaging with Structured Reports and Retrieval Augmentation

A study published in Dermatology Practical & Conceptual investigated the effectiveness of retrieval-augmented generation (RAG) and structured radiologist reporting in enhancing the diagnostic performance of vision-capable large language models (LLMs) in dermatologic ultrasound. The research assessed dermatologic ultrasound cases with histopathological reference standards under four conditions: image-only without retrieval, image-only with retrieval, image plus radiologic report without retrieval, and image plus radiologic report with retrieval. The findings indicate that while image-only performance was limited and did not significantly improve with retrieval augmentation alone, the integration of structured radiologic reports led to a notable increase in diagnostic accuracy and the generation of differential diagnoses. The highest accuracy was observed when both structured reports and retrieval augmentation were utilized, suggesting a synergistic effect between these two components. The study used a visio...